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Differences in puromycin aminonucleoside nephrosls in two ratstrains.
Administration of puromycin aminonucleoside (PAN) to Wistar rats
induces proteinuria and enhanced mesangial deposition of circulating
macromolecules. After proteinuria of longer duration focal and segmen-
tal glomerular hyalinosis and sclerosis (FSGHS) develops, The present
report analyzes these aspects of PAN nephrosis in PVG/c rats, a strain
previously shown to be remarkably resistant to proteinuria and FSGHS
with aging or after uninephrectomy. In Wistar rats multiple injections of
PAN during five months resulted in sustained severe proteinuria and
FSGHS lesions in 8.1 1.0% (mean I sEM) of their glomeruli (N =
6). In PVG/c rats a 1.3-fold higher dose of PAN was needed to induce
chronic proteinuria similar to the Wistar rats. After five months 3.3
0.9% of their glomeruli showed FSGHS (N = 6, P < 0.01) and the
glomerular lesions were considerably less advanced. In acute PAN
nephrosis induced by a single intravenous injection of PAN the mesan-
gium of Wistar rats contained large amounts of lipid in contrast to a few
small mesangial lipid droplets in nephrotic PVG/c rats. After injection
of colloidal carbon in nephrotic PVG/c rats no enhanced carbon
accumulation was found in the mesangium when compared to non-
proteinuric controls. This result clearly differs from the increased
mesangial sequestration of circulating material in nephrotic Wistar, and
most other rat strains. The unchanged mesangial traficking of macro-
molecules in nephrotic PVG/c rats and the low incidence of FSGHS
lesions in the presence of sustained glomerular proteinuria may reflect
a relative resistance to PAN-induced glomerular damage in this partic-
ular rat strain.
A large number of animal models is now available to study
etiologic, pathogenetic, and therapeutic aspects of chronic renal
failure. Aging male rats of most strains gradually develop
proteinuria associated with progressive renal functional deteri-
oration and structural alterations, such as focal and segmental
glomerular hyalinosis and sclerosis (FSGHS), much resembling
chronic renal disease in man. The development of FSGHS in
rats can be accelerated by a variety of stimuli such as surgical
removal of variable amounts of kidney tissue, renal infarction,
irradiation, induction of diabetes mellitus, hormonal treatment,
immunologic injury to the kidneys, injections of nephrotoxic
agents, and combinations of these maneuvers [1]. Not all rat
strains bear the same susceptibility for the development of
FSGHS [2]. No development of age-dependent FSGHS has
been reported in Wistar Kyoto rats [3] and rats of the Milan
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hypertensive strain [4]. Recently, we documented a remarkable
resistancy of rats of the PVG/c strain to FSGHS upon aging or
after unilateral nephrectomy [5]. The present study extends
these observations and reports a relatively low incidence of
FSGHS associated with a strikingly normal mesangial handling
of macromolecules in PVG/c rats with puromycin aminonucle-
oside nephrosis.
Methods
Animals
Male Wistar rats and inbred PVG/c rats (haplotype RT1 . c/c)
were obtained from the same colonies as used in the previous
study [5]. All animals were three months of age at the start of
the experiments. They were fed a normal rat chow with a
sodium content of 0.44% and a digestible protein content of 22%
(Hope Farms, Woerden, The Netherlands) with free access to
tap water.
Proteinuria
Urine was collected from rats housed for 24 hours in meta-
bolic cages with access to tap water only. Protein excretion was
measured with the biuret method.
Chronic puromycin aminonucleoside nephrosis
Six Wistar and six PVGIc rats were injected subcutaneously
with puromycin aminonucleoside (PAN, Sigma Chemical Co.,
St. Louis, Missouri, USA). In Wistar rats a dose of 20 mg per
kg body weight dissolved in 1 ml of saline was given weekly
during the first three weeks, and subsequently 10 mg per kg
body weight every other week [6, 7]. The dose of PAN
administered to the PVG/c rats was increased in such a way that
mean proteinuria of the PVG/c rats was comparable to that of
the Wistar rats. Proteinuria was measured weekly. Seven rats
of both strains were injected with 1 ml of saline at the same time
intervals and served as controls. All animals were killed after
five months. Kidney tissue was fixed by immersion in 8%
buffered formalin for 24 to 48 hours at room temperature and
embedded in glycol methacrylate. Sections were cut at 2 sm on
a Sorvall-JB-4 microtome and stained with periodic acid Schiff
(PAS). Coronal sections (two per kidney with an interspace of
150 pm) of both kidneys of each rat were screened at a
magnification of x 250 by light microscopy to determine the
percentage of glomeruli with FSGHS. Per kidney at least 100
glomeruli were studied. FSGHS was defined according to the
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criteria put forward by Habib [81 consisting of a glomerular
lesion with deposition of hyalin amorphous material in mesan-
glum and subendothelium ("hyalinosis") with increase of
mesangial matrix material, capillary lumen obliteration with
collapse, and synechiae to the Bowman's capsule ("sclerosis").
The degree of damage in the affected glomeruli was scored
semiquantitatively from 0 to 4 according to the percentage of
glomerular involvement as designed by Raij, Azar and Keane
[9]. In this system a l lesion represents 25% involvement of
the glomerulus and a 4 lesion complete glomerular hyaliniza-
tion.
Acute puromycin aminonucleoside nephrosis
After a single intravenous injection of PAN (acute PAN
nephrosis) Wistar rats of our colonies show a considerably
enhanced mesangial accumulation of endogenous lipids [61 and
intravenously injected tracer such as colloidal carbon [10]. This
well known effect of PAN on the mesangium has been reported
by many authors in other rat strains as well [11—13]. In the
present experiments mesangial macromolecular kinetics in
PVG/c rats with acute PAN nephrosis were studied. Mesangial
lipid content of nephrotic Wistar rats was compared to that of
PVG/c rats after PAN injection. In these experiments five
Wistar rats received a single intravenous injection of 60 mg of
PAN per kg body weight dissolved in 3 ml of isotonic saline.
Since preliminary studies indicated that PVG/c rats were con-
siderably less sensitive to the nephrotoxic effect of PAN, a
group of 10 PVGIc rats received a dose of 150mg of PAN per kg
body weight intravenously. Urine was collected from day 9 to
10 to measure protein excretion. The animals were killed on day
10 and blood was collected for determination of the serum
levels of cholesterol. The group of Wistar rats was matched
with five PVG/c rats with similar levels of serum cholesterol
being the lipid preferentially deposited in glomeruli during PAN
nephrosis [14]. For the detection of glomerular lipid, tissue from
both kidneys was snap-frozen in precooled Freon at —90°C.
Cryostat sections (3 sm) were stained with Oil Red 0. For light
microscopic examination the sections were counterstained with
hematoxylin. For semiquantitative analysis of glomerular lipid
ORO-stained sections without counterstaining were measured
with the use of a modular scanning image analyzer (Optomax,
Ealing Beck, Ltd., Whatford, UK). As described previously [6,
7], this method is a point counting method in which the total
number of points covered by a contrasted area is counted and
serves as a measure of the total area of ORO-positive material
present in the glomerulus. The threshold of sensitivity was
chosen in such a way that only ORO-positive areas gave
sufficient contrast for detection by the scanner. All measure-
ments were performed using the same level of sensitivity. In
each section 25 consecutive glomeruli sectioned through their
largest or nearby largest diameter were scanned moving
through the cortex from surface to medulla and vice versa.
Mean count number per glomerulus was taken as a measure of
glomerular lipid content of that rat and the mean count numbers
of all rats as the value of the group. In addition, mesangial
macromolecular kinetics in PVG/c rats were further studied by
comparison of mesangial processing of i.v. injected colloidal
carbon (CC) of nephrotic PVG/c rats with that of non-
proteinuric controls, exactly following the procedure used
previously by us in Wistar rats [6, 10]. A single i.v. dose of 90
mg of PAN per kg body weight dissolved in 3 ml of isotonic
saline was injected into seven male PVG/c rats. Five controls
received saline. Before and seven days after PAN injection
urine was collected for protein determination. At day 9 all
animals received 20 mg CC per 100 g of body weight intrave-
nously (CC for biological use, Cl 111431A, Gunther Wagner,
Hannover, Germany, containing 100 mg of CC per ml). Blood
levels of carbon were measured by optical density at a wave
length of 650 nm and the phagocytic index K, which character-
izes the rate of CC clearance from the circulation, was calcu-
lated. Biopsies were taken from the right kidney via a flank
incision under ether anesthesia at 24 hours after CC injection.
Kidneys were obtained at autopsy after seven days. The
material was fixed by immersion and embedded in plastic. One
set of slides of 2 m thickness was stained with PAS for light
microscopic study, another set of slides was left unstained for
the measurement of the amount of mesangial CC using the
Optomax system. In each tissue specimen measurements were
made of 25 consecutive glomeruli and mean count number per
glomerulus was taken as a measure of mesangial carbon content
of that kidney or biopsy. For a more detailed analysis, glomeruli
of the PAN and control rats at the 24 hour interval after CC
injection were grouped in classes of increasing count number
with a class range of 30 counts [7, 15].
Statistical analysis
Values are presented as mean 1 standard error of the mean
(sEM). Statistical evaluation was carried out using the two-sided
Student's t-test or the Mann-Whitney U test, with the level of
significance being defined as P < 0.05.
Results
Chronic puromycin aminonucleoside nephrosis
At the start of this experiment mean body weight of the
Wistar group was 233 3 g (N = 13), of the PVG/c group 255
3 g (N = 13). Mean body weight of Wistar rats after five
months of repeated PAN injections was 398 12 g (N = 6), of
saline injected controls it was 409 14 g (N = 7, NS). Both
nephrotic and control PVG/c rats showed a lower weight gain.
At sacrifice mean body weight of the nephrotic PVG/c rats was
338 4 g (N = 6), of saline injected controls 349 4 g (N = 7,
NS). Protein excretion in PAN-injected Wistar and PVG/c rats
is illustrated in Figure 1. Mean protein excretion during the
experimental period of five months in the Wistar rats was 145
12 mg, in the PAN-injected PVG/c rats it was 131 11 mg per
24 hours (NS). The total amount of PAN required to induce and
maintain protein excretion of the PVG/c rats, similar to that of
the Wistar rats, was 200 mg per kg body weight. Wistar rats
received a total amount of 150 mg per kg body weight. Protein
excretion in saline-injected control Wistar rats was 26 2 mg,
in control PVG/c rats it was 27 3 mg per 24 hours.
Characteristic FSGHS lesions consisting of segmental
mesangial and subendothelial deposition of hyalinized PAS-
positive material with an increase of mesangial matrix sub-
stance, capillary wall wrinkling with collapse, and synechiae to
the Bowman capsule were found at autopsy in kidneys of both
Wistar and PVG/c rats (Fig. 2, Table 1). In both strains the
affected glomeruli were distributed equally in the juxtame-
dullary and outer position of the cortex, and no stratification of
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the lesions was observed. Compared to Wistar rats the percent-
age of glomeruli showing FSGHS in PVG/c kidneys was signif-
icantly lower with considerably less extended glomerular in-
volvement (Table 1). Numerous protein absorption droplets
were observed in glomerular visceral epithelial cells of sclerotic
and non-sclerotic glomeruli of both strains. The kidneys further
showed focal tubular atrophy, tubular intraluminal protein
casts, patchy chronic inflammatory infiltrate, and protein drop-
lets in tubular epithelium.
Acute puromycin aminonucleoside nephrosis
Both Wistar and PVG/c rats were heavily nephrotic 10 days
after PAN injection. At autopsy ascites was marked, particu-
larly in the PVGIc rats. Table 2 shows the biochemical and
morphological data. To compare mesangial lipid the animals
were matched on the basis of serum cholesterol levels, these
being approximately tenfold increased in both groups of rats
Percentage glomeruli
with FSGHS
mean 1 SEM 1
Degree of damage in
FSGHS glomeruli %2 3 4
WistarN=
PVG/c N =
6
6
8.1 1.0
3.3 0.9
32
73
41 22 5
25 2 0
Serum cholesterol
mmol/liter
Proteinuria
mg/24 hr
Glomerular lipid
countsl
glomerulus
WistarN 5 11.1 1.0 330 43 48.9 13.0
PVG/cN=5 10.2± 1.4
NS
180±23
P < 0.01
7.6±2.1
P < 0.025
(normal value less than 1.7 mmol/liter in both strains). How-
ever, proteinuria of Wistar rats significantly exceeded that of
the selected PVG/c rats despite a lower dose of PAN. Light
microscopic examination did not reveal glomerular lesions in
Wistar or PVG!c kidneys apart from numerous protein droplets
in visceral epithelium. ORO-staining disclosed many small and
large lipid deposits in the glomeruli of Wistar rats located in a
mesangial pattern (Fig. 3A). Glomeruli of PVG/c rats contained
only a few small lipid droplets (Fig. 3B). Semiquantitative
analysis showed significantly larger quantities of glomerular
lipid in Wistar rats compared to that in PVG/c rats (Table 2). No
mesangial lipid deposits were found in glomeruli of normal
Wistar and PVG/c rats.
Mean urinary protein excretion in the PAN-injected PVG/c
rats used in the carbon studies was 123 8 mg per 24 hours (N
= 7) at day 7; in saline-injected controls mean level of urinary
protein was 15 6 mg per 24 hours (P < 0.001). CC clearance
from the blood did not differ between nephrotic and control rats
(KPAN 0.0161 0,0014, CC blood level at 5 minutes 3.28
mg/mI; Kontrois = 0.0170 0.0016, CC blood level at 5 minutes
3.19 mg/mi). Light microscopic examination did not reveal
differences in mesangial CC content between nephrotic and
control PVG/c rats one day (Fig. 4) and seven days after CC
injection. In both groups there was considerable variation in the
quantity of CC among glomeruli and within the lobules of the
glomeruli. The quantity of CC did not differ between superficial
and juxtamedullary glomeruli. Semiquantitative analysis of the
amount of mesangial carbon is presented in Table 3. Neither at
one day nor at seven days after CC injection were differences
found between nephrotic and control PVG/c rats. When the
frequency distribution of glomeruli over the different count
classes of nephrotic rats was compared to that of controls,
identical distribution patterns were found (Fig. 5).
Discussion
This report extends previous studies that have examined
strain differences in the development of proteinuria and FSGHS
with aging and the acceleration of these changes with
Table 1. Glomerular pathology in Wistar and PVG/c rats after
chronic PAN nephrosis of 5 months duration
5
A AA £ £AAkLIP
0
Time, weeks
Table 2. Serum cholesterol levels, proteinuria, and glomerular lipid
10 15 20 content of Wistar and PVG/c rats injected 10 days previously with 60
mg and 150 mg of PAN per kg body weight, respectively
(mean values 1 SEM)
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Fig. 1. Proteinuria of Wistar (W) and PVG/c (PP) rats in response to
repetitive subcutaneous injections of 20 mg per kg (Large arrow heads)
and 10 mg per kg body weight (small arrow heads).
Fig, 2, Glomerulus of PVG/c rat after 5 months of persistent protein-
uria. A 2 FSGHS lesion is shown with insudations, capillary lumen
obliteration and collapse, and adhesions to the Bowman's capsule.
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Fig. 3A. Glomerulus of a Wistar rat 10 days
after intravenous injection of 60 mg of PAN
per kg body weight. Many small and large
lipid droplets are present in a mesangial
pattern (arrow heads). ORO and Hematox-
ylin, x 350. B. Glomerulus of a PVG/c rat 10
days after PAN injection (150 mg per kg
body weight). A few small lipid deposits are
seen (arrow heads). ORO and Hematoxylin,
x 350.
Fig. 4A. Glomerulus of a PAN injected PVG/c rat with heavy proteinuria 24 hours after CC injection, CC is localized in the glomerular mesangial
area. Protein reabsorption droplets are present in the glomerular epithelium (arrow). PAS, x 560. B. Glomerulus of a control PVG/c rat. The
amount of CC localized in the mesangium 24 hours after intravenous injection is equal to that in Figure 5A. PAS, x 560.
uninephrectomy [5]. In the current experiments rats of this
particular FSGHS-resistant PVGIc strain were found to be
remarkably less sensitive to the proteinuric effect of PAN when
compared to Wistar rats. In chronic PAN nephrosis higher
doses of PAN were needed to induce proteinuria in PVG/c rats
equal to Wistar rats. In acute PAN nephrosis PVG/c rats even
failed to reach the urinary protein levels of Wistar rats, despite
a more than 200 per cent higher intravenous dosage of PAN
(Table 2). PAN exerts a rapid direct biochemical effect on the
kidney independent of any systemic effect, as shown by Hoyer
and coworkers in transplantation and selective renal perfusion
experiments [12, 161, although the proteinuria occurs after a lag
period of several days. Although many studies, both in vivo and
in vitro, have been addressed to this model, and in particular
have focused on the morphological and biochemical changes of
the visceral glomerular epithelial cell [17—19], the precise bio-
chemical insult at the cellular level is not entirely clear. Our
current study cannot make further contributions on this issue.
However, the relatively modest proteinuria in response to PAN
injection when compared to Wistar and most other rat strains
may indicate an uncommon metabolism of glomerular visceral
epithelial cells in PVG/c rats. Interestingly, administration of
adriamycin, another nephrotoxic agent causing epithelial cell
damage and proteinuria in rats by a direct toxic effect on the
kidney [6, 20], to PVG/c rats likewise induced a relatively low
proteinuric response when compared with Wistar rats [21].
Aging and uninephrectomized rats which develop FSGHS
lesions already show increased urinary protein loss before
glomerular hyalinosis and sclerosis have developed [22—25] and
this is even more clear in rats made proteinuric by injections
with PAN [6, 7, 26, 27]. Thus, proteinuria and development of
FSGHS seem to be strictly related phenomena although the
question remains whether they are causally related or separate
expressions of glomerular injury [6]. The present data show that
when PVGIc rats are made proteinuric by high dosages of PAN,
they indeed develop FSGHS be it in a low percentage of their
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1 day 7 days
PANN=
Saline N =
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15.1±2.3
18.7 2.4
3.3±
4.2
1.4
1.8
P NS NS
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glomeruli with considerably less extended glomerular involve-
ment than in Wistar rats.
The pathogenesis of FSGHS is only partially understood.
Many experimental models, mainly in rats, have been described
in which FSGHS-like lesions develop [1, 2]. Suggestions for a
pathogenesis of these glomerular lesions include amino acid
toxicity [28, 291, impaired cellular immunity [30, 31], mechan-
ical stress due to intraglomerular hypertension and hyperperfu-
sion [32, 33], coagulation [34, 351, damage of visceral epithelium
with development of synechiae and capillary collapse [27, 36],
abnormalities of mesangial cell growth regulation secondary to
visceral epithelial and endothelial cell injury [36—38], and
mesangial changes associated with or caused by accumulations
of proteins and lipids with matrix overproduction and scarring,
analogous to arterial wall damage in atherosclerosis [6, 14, 15,
22, 39]. Evolution of the glomerular morphologic changes in the
rat associated with hyperfiltration secondary to ablation of renal
mass (uninephrectomy and partial infarction of the contralateral
kidney) are documented by Rennke [331. Four basic pathologic
processes ultimately lead to glomerulosclerosis: microthrombo-
sis, microaneurysma formation, subendothelial hyalin deposi-
tion, and mesangial expansion [331. In the PAN model of
FSGHS however, hyperfiltration is absent, at least in its early
phases, with markedly decreased glomerular filtration and
plasma flow rates [40, 411. Epithelial and mesangial damage
may be more important determinants of FSGHS in this model
[7, 17, 19, 27, 36, 371. On the basis of previous own observa-
tions in Wistar rats with chronic PAN nephrosis [6, 7], attention
was paid to the mesangial handling of circulating endogenous
lipids and injected colloidal carbon in PVG/c rats made
proteinuric with PAN. Morphometric analysis of ORO-stained
sections of Wistar and PVG/c rats matched on serum choles-
terol levels using circulating lipids as an "endogenous tracer"
[6, 14] indicated only modest lipid accumulation in the mesan-
gium of nephrotic PVG/c rats, in contrast to large lipid deposits
in glomeruli of Wistar rats. Matching on serum lipid levels
resulted in different levels of urinary protein excretion between
these groups of rats with acute PAN nephrosis (Table 2). Many
authors, however, have shown that the sequestration of in-
jected CC, aggregated IgG, or immune complexes in PAN
nephrosis [11, 12, 42], nephrotoxic serum nephritis [42, 43],
autologous immune complex glomerulonephritis [13, 44,45] and
adriamycin nephrosis [6, 131 is not directly related to the
magnitude of proteinuria. In contrast to the considerably en-
hanced mesangial deposition of CC, aggregated IgG, and lipids
in PAN-injected Sprague-Dawley, Lewis, and Wistar rats
[10—12, 42] the uptake and removal of CC by the mesangium of
nephrotic PVG/c rats was identical to that of non-proteinuric
controls. This unmodified mesangial handling of circulating
macromolecules in PVG/c rats with PAN nephrosis constitutes
a crucial observation in this study, although the mechanism
underlying this phenomenon remains unexplained from our
data. The relatively low occurrence of FSGHS in this particular
rat strain may be related to this unchanged mesangial behavior
in the presence of severe proteinuria [39].
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